Your Location:Home >Products >small-molecule inhibitor >478-84-2
pd_meltingpoint:120-127°
Purity:99%
Safety Profile |
Poison by intraperitoneal and intravenous routes. Experimental teratogenic and reproductive effects. Human systemic effects by ingestion: ddation of the arteries or veins. Many lysergic acid derivatives have central nervous system effects. When heated to decomposition it emits very toxic fumes such as Brand NOx. See other lysergic acid derivatives. |
InChI:InChI=1/C20H24BrN3O/c1-4-24(5-2)20(25)12-9-14-13-7-6-8-16-18(13)15(19(21)22-16)10-17(14)23(3)11-12/h6-9,12,17,22H,4-5,10-11H2,1-3H3/t12-,17-/m1/s1
The present invention provides an improv...
A new and improved bromination of α-ergo...
lysergide
2-bromo-lysergide
Conditions | Yield |
---|---|
With
pyridazinium bromide; 3-bromo-6-chloro-2-methylimidazo;
In
dichloromethane;
for 0.0333333h;
Ambient temperature;
|
73.4% |
/BRN= 42790/;
|
2-bromo-lysergide
Conditions | Yield |
---|---|
|
73.4% |
lysergide
2-bromo-1,6-dimethyl-9,10-didehydro-ergoline-8β-carboxylic acid diethylamide
CAS:56-94-0
CAS:1000018-10-9
CAS:5950-12-9